Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States

By sjmartinez • February 21, 2025

Pak K, Sachar R, Saab S. Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States. Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909-z. Epub ahead of print. PMID: 39979574.

Tags: Digestive Diseases, Gray zone, HCC, hepatitis B, Immune-tolerant, Publications

Increasing Goals of Care Discussions Among Veterans with Cirrhosis: A Veterans Health Administration Quality Improvement Initiative

Patel AA, O'Leary JG, Bajaj JS, Prause N, Hannum R, Noll A, Cheung R, Giustini AB, Jakab SS, Nobbe A, Patton H, Perumalswami P, Spoutz[...]

Mechanisms and therapeutic insights into MASH-associated fibrosis

Zhu Y, Cai B. Mechanisms and therapeutic insights into MASH-associated fibrosis. Trends Endocrinol Metab. 2025 Sep 26:S1043-2760(25)00196-1. doi: 10.1016/j.tem.2025.09.004. Epub ahead of print. PMID: 41015698.

Functional alterations across motor, visual, and attention cerebellar and cortical networks in patients with asymptomatic spinal cord compression

Kostiuk A, Jafari M, Wang C, Mayer E, Salamon N, Holly LT, Ellingson BM. Functional alterations across motor, visual, and attention cerebellar and cortical networks[...]